Market revenue in 2023 | USD 24.9 million |
Market revenue in 2030 | USD 32.9 million |
Growth rate | 4.1% (CAGR from 2023 to 2030) |
Largest segment | Mammalian source |
Fastest growing segment | Mammalian Source |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Microbial Source, Mammalian Source, Other Source |
Key market players worldwide | WuXi Biologics (Cayman) Inc, FUJIFILM Holdings Corp, AGC Biologics, Thermo Fisher Scientific Inc, Curia, Genscript Biotech Corp Class H, Boehringer Ingelheim Pharma, Abzena, JSR Corp, Bionova Scientific |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biologics contract development market will help companies and investors design strategic landscapes.
Mammalian source was the largest segment with a revenue share of 60.24% in 2023. Horizon Databook has segmented the South Africa biologics contract development market based on microbial source, mammalian source, other source covering the revenue growth of each sub-segment from 2018 to 2030.
The South African market is expected to exhibit growth owing to well-established infrastructure, diverse patient population, skilled researchers, presence of a separate drug regulatory agency, and easy patient recruitment.
In order to accelerate the drug registration process, a new drug regulatory agency named South African Health Products Regulatory Authority (SAHPRA) was established in August 2013. In January 2014, Novotech expanded its services in South Africa.
In Africa, the South African region is the most developed owing to its high disease burden and diverse population base. The company carried out trials for HIV & tuberculosis and hired staff locally. There were around 1,700 registered studies as per the South African Department of Health Online Registry.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa biologics contract development market, including forecasts for subscribers. This country databook contains high-level insights into South Africa biologics contract development market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account